Biomarkers and Pathology

One imperative part of the part of Pathology in the assessment of bosom malignancy is biomarker trying, particularly the precise appraisal of the estrogen receptor (ER), progesterone receptor (PR), and Her2 status of a patient's bosom tumor. Biomarkers can be prognostic, prescient, or both. Prognostic biomarkers are free measures of forecast to such an extent that the nearness or nonappearance of the biomarker is connected with a patient's general clinical result (i.e., danger of repeat and mortality).

  • Molecular Pathology
  • Clinical Pathology

Related Conference of Biomarkers and Pathology

Aug 21-22 2017

World Medical Laboratory Congress & Expo

San Francisco, USA
Aug 21-22, 2017

3rd International Conference on Autism

Los Angeles, USA
October 18-20, 2017

10th World Congress on Biomarkers & Clinical Research

Baltimore, USA
October 23-25, 2017

Medical Technology- 2017 (CME & CPD Accredited)

London, UK
October 23-25, 2017

Surgery- 2017 (CME & CPD Accredited)

London, UK
October 23-25, 2017

Ophthalmology- 2017 (CME & CPD Accredited)

London, UK
November 13-15, 2017

Neurology- 2017 (CME & CPD Accredited)

Valencia, Spain
November 13-15,2017

17th World Fitness Expo

(10 Plenary Forums - 1Event) Atlanta, USA
December 07-09, 2017

Biomedical- 2017 (CME & CPD Accredited)

Frankfurt, Germany

Biomarkers and Pathology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in